The outlook of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key territories has introduced significant uncertainty . Investors are now assessing the consequences of lower-co